Does Evidence Support the American Heart Association's Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Thombs, Brett D ^a,b   Roseman, Michelle ^a,b   Coyne, James C ^c,d   de Jonge, Peter ^d   Delisle, Vanessa C ^a,b   Arthurs, Erin ^b   Levis, Brooke ^a,b   Ziegelstein, Roy C ^e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PLACEBO; SERTRALINE;

CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT DURATION;

AMERICAN HEART ASSOCIATION; ANTIDEPRESSIVE AGENTS; CORONARY DISEASE; DEPRESSIVE DISORDER; HUMANS; PROGNOSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84872020198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052654     Document Type: Review

References (64)

1. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, et al. (2006) Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21 (1):: 30-38.
2. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, et al. (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 33 (3):: 203-216.
3. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, et al. (2008) Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Circulation. 118 (17):: 1768-1775.
4. Wilson JM, Jungner G (1968) Principles and practices of screening for disease. Geneva: World Health Organization.
5. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, et al. (2008) Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA 300 (18):: 2161-2171.
6. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, (2009) et al. 2009 ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 54 (22):: 2102-2128.
7. Thombs BD, Jewett LR, Knafo R, Coyne JC, Ziegelstein RC, (2009) Learning from history: A commentary on the American Heart Association science advisory on depression screening. Am Heart J 158 (4):: 503-505.
8. Cruz LN, Fleck MP, Polanczyk CA, (2010) Depression as a determinant of quality of life in patients with chronic disease: Data from Brazil. Soc Psychiatry Psychiatr Epidemiol 45 (10):: 953-961.
9. Frasure-Smith N, Lesperance F, (2008) Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 65 (1):: 62-71.
10. Elderon L, Smolderen KG, Na B, Whooley MA, (2011) Accuracy and prognostic value of American Heart Association-recommended depression screening in patients with coronary heart disease. Circ Cardiovasc Qual Outcomes 4 (5):: 533-540.
11. Thombs BD, Ziegelstein RC, Whooley MA, (2008) Optimizing detection of major depression among patients with coronary artery disease using the Patient Health Questionnaire: Data from the Heart and Soul Study. J Gen Intern Med 23 (12):: 2014-2017.
12. Huffman JC, Doughty CT, Januzzi JL, Pirl WF, Smith FA, et al. (2010) Screening for major depression in post-myocardial infarction patients: Operating characteristics of the Beck Depression Inventory-II. Int J Psychiatry Med 40 (2):: 187-197.
13. Jacq F, Foulldrin G, Savoure A, Anselme F, Baguelin-Pinaud A, et al. (2009) A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry 31 (3):: 266-273.
14. Pinho MX, Custodio O, Makdisse M, Carvalho AC, (2010) Reliability and validity of the Geriatric Depression Scale in elderly individuals with coronary artery disease. Arq Bras Cardiol 94 (5):: 570-579.
15. Tiringer I, Simon A, Herrfurth D, Suri I, Szalai K, et al. (2008) Occurrence of anxiety and depression disorders after acute cardiac events during hospital rehabilitation. application of the Hospital Anxiety and Depression Scale as a screening instrument. Psychiatr Hung 23 (6):: 430-443.
16. Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, et al. (2011) Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: A prospective cohort study of 195 patients with coronary artery disease. J Clin Psychiatry 72 (9):: 1181-1188.
17. Bunevicius A, Staniute M, Brozaitiene J, Bunevicius R, (2012) Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients. J Psychosom Res 72 (1):: 22-25.
18. Dickens CM, Percival C, McGowan L, Douglas J, Tomenson B, et al. (2004) The risk factors for depression in first myocardial infarction patients. Psychol Med 34 (6):: 1083-1092.
19. Frasure-Smith N, Lesperance F, Talajic M, (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91 (4):: 999-1005.
20. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, et al. (2003) Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 65 (1):: 119-128.
21. Gutierrez RC, (1999) Assessing depression in patients with congestive heart failure. Can J Cardiovasc Nurs 10 (4):: 29-36.
22. McManus D, Pipkin SS, Whooley MA, (2005) Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 96 (8):: 1076-1081.
23. Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, et al. (2006) Rapid screening for major depression in post-myocardial infarction patients: An investigation using Beck Depression Inventory II items. Heart 92 (11):: 1656-1660.
24. Low GD, Hubley AM, (2007) Screening for depression after cardiac events using the Beck Depression Inventory-II and the Geriatric Depression Scale. Soc Indic Res 82: 527-543.
25. Stafford L, Berk M, Jackson HJ, (2007) Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 29 (5):: 417-424.
26. Strik JJ, Honig A, Lousberg R, Denollet J, (2001) Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 42 (5):: 423-428.
27. Denollet J, Strik JJ, Lousberg R, Honig A, (2006) Recognizing increased risk of depressive comorbidity after myocardial infarction: Looking for 4 symptoms of anxiety-depression. Psychother Psychosom 75 (6):: 346-352.
28. Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, et al. (2009) A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms. Contemp Clin Trials 30 (3):: 205-211.
29. O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, et al. (2010) Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56 (9):: 692-699.
30. Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, et al. (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297 (4):: 367-379.
31. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, et al. (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) randomized trial. JAMA 289 (23):: 3106-3116.
32. Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, et al. (2007) Treatment of post-myocardial infarction depressive disorder: A randomized, placebo-controlled trial with mirtazapine. Psychosom Med 69 (7):: 606-613.
33. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AM, et al. (2007) Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 190: 460-466.
34. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (6):: 701-709.
35. Strik JJ, Honig A, Lousberg R, Lousberg AH, Cheriex EC, et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosom Med 62 (6):: 783-789.
36. Thombs BD, Coyne JC, Cuijpers P, de Jonge P, Gilbody S, et al. (2012) Rethinking recommendations for screening for depression in primary care. CMAJ 184 (4):: 413-418.
37. Gilbody SD, Sheldon TD, House AD, (2008) Screening and case-finding instruments for depression: A meta-analysis. CMAJ 178 (8):: 997-1003.
38. Sowden G, Mastromauro CA, Januzzi JL, Fricchione GL, Huffman JC, (2010) Detection of depression in cardiac inpatients: Feasibility and results of systematic screening. Am Heart J 159 (5):: 780-787.
39. Smolderen KG, Buchanan DM, Amin AA, Gosch K, Nugent K, et al. (2011) Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients: Implications for the American Heart Association depression screening advisory. Circ Cardiovasc Qual Outcomes 4 (3):: 283-292.
40. Subramanian DN, Hopayian K, (2008) An audit of the first year of screening for depression in patients with diabetes and ischaemic heart disease under the quality and outcomes framework. Qual Prim Care 16 (5):: 341-344.
41. Annunziato RA, Rubinstein D, Sheikh S, Maurer M, Cotter G, et al. (2008) Site matters: Winning the hearts and minds of patients in a cardiology clinic. Psychosomatics 49 (5):: 386-391.
42. Burton C, Simpson C, Anderson N, (Epub ahead of print) Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study. Psychol Med.
43. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, et al. (2011) AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124 (22):: 2458-2473.
44. Ziegelstein RC, Thombs BD, Coyne JC, de Jonge P, (2009) Routine screening for depression in patients with coronary heart disease- never mind. J Am Coll Cardiol 54 (10):: 886-890.
45. U.S. Preventive Services Task Force (2009) Screening for depression in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151 (11):: 784-792.
46. National Collaborating Center for Mental Health (2010) The NICE guideline on the management and treatment of depression in adults (updated edition).
47. Czarny MJ, Arthurs E, Coffie DF, Smith C, Steele RJ, et al. (2011) Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: A systematic review. PLoS One 6 (11):: e27671.
48. Benazon NR, Mamdani MM, Coyne JC, (2005) Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002. Psychosom Med 67 (6):: 916-920.
49. Thombs BD, Arthurs E, El-Baalbaki G, Meijer A, Ziegelstein RC, et al. (2011) Risk of bias from inclusion of already diagnosed or treated patients in diagnostic accuracy studies of depression screening tools: A systematic review. BMJ 343: d4825.
50. Manea L, Gilbody S, McMillan D, (2011) Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ.
51. Ziegelstein RC, Thombs BD, (2011) Is routine screening a parachute for heart disease patients with depression? J Psychosom Res 71 (1):: 3-5.
52. Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E, (2011) Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 183 (16):: 1835-1843.
53. Schalekamp T, Klungel OH, Souverein PC, de Boer A, (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168 (2):: 180-185.
54. Schelleman H, Brensinger CM, Bilker WB, Hennessy S, (2011) Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS One 6 (6):: e21447.
55. Spina E, Santoro V, D'Arrigo C, (2008) Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clin Ther 30 (7):: 1206-1227.
56. Goryachkina K, Burbello A, Boldueva S, Babak S, Bergman U, et al. (2008) Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI). Eur J Clin Pharmacol 64 (3):: 275-282.
57. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 (4):: 287-291.
58. Stahl SM, Grady MM, Moret C, Briley M, (2005) SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10 (9):: 732-747.
59. Licht CM, de Geus EJ, van Dyck R, Penninx BW, (2010) Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 68 (9):: 861-868.
60. U.S. Food and Drug Administration (2012) Celexa (citalopram hydrobromide): Drug safety communication- abnormal heart rhythms associated with higher doses. Available: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm269481.htm. Accessed 21 November 2012.
61. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, et al. (2009) Depression and risk of sudden cardiac death and coronary heart disease in women: Results from the Nurses' Health Study. J Am Coll Cardiol 53 (11):: 950-958.
62. Krantz DS, Whittaker KS, Francis JL, Rutledge T, Johnson BD, et al. (2009) Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study. Heart 95 (23):: 1901-1906.
63. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, et al. (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med 169 (22):: 2128-2139.
64. Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, et al. (2006) Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 98 (1):: 42-47.